|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
ELV033961646 |
003 |
DE-627 |
005 |
20230624001922.0 |
007 |
cr uuu---uuuuu |
008 |
180603s2014 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.earlhumdev.2014.02.003
|2 doi
|
028 |
5 |
2 |
|a GBVA2014012000026.pica
|
035 |
|
|
|a (DE-627)ELV033961646
|
035 |
|
|
|a (ELSEVIER)S0378-3782(14)00047-4
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
082 |
0 |
|
|a 610
|
082 |
0 |
4 |
|a 610
|q DE-600
|
082 |
0 |
4 |
|a 618.3/005
|q OCLC
|
082 |
0 |
4 |
|a 610
|q VZ
|
082 |
0 |
4 |
|a 610
|q VZ
|
084 |
|
|
|a 44.45
|2 bkl
|
100 |
1 |
|
|a DeRienzo, Chris
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Feeding practices and other risk factors for developing transfusion-associated necrotizing enterocolitis
|
264 |
|
1 |
|c 2014
|
300 |
|
|
|a 4
|
336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
520 |
|
|
|a The objective of this study is to determine the incidence of and risk factors for necrotizing enterocolitis (NEC) and transfusion-associated NEC (TANEC) in very-low-birth-weight (VLBW) infants pre/post implementation of a peri-transfusion feeding protocol.
|
700 |
1 |
|
|a Smith, P. Brian
|4 oth
|
700 |
1 |
|
|a Tanaka, David
|4 oth
|
700 |
1 |
|
|a Bandarenko, Nicholas
|4 oth
|
700 |
1 |
|
|a Campbell, Mary Lee
|4 oth
|
700 |
1 |
|
|a Herman, Annadele
|4 oth
|
700 |
1 |
|
|a Goldberg, Ronald N.
|4 oth
|
700 |
1 |
|
|a Cotten, C. Michael
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
773 |
1 |
8 |
|g volume:90
|g year:2014
|g number:5
|g pages:237-240
|g extent:4
|
856 |
4 |
0 |
|u https://doi.org/10.1016/j.earlhumdev.2014.02.003
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_U
|
912 |
|
|
|a GBV_ELV
|
912 |
|
|
|a SYSFLAG_U
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_350
|
936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 90
|j 2014
|e 5
|h 237-240
|g 4
|
953 |
|
|
|2 045F
|a 610
|